Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Event Logistics

- PMLiVE

Richard Douglas joins Incisive Health

He takes up a role at the healthcare comms consultancy as senior counsel

Bayer symbol

Bayer picks strategy head for top post

Werner Baumann will take over from Dr Marijn Dekkers

- PMLiVE

FDA rejects PTC’s application for muscular dystrophy drug

Says Translarna filing not “sufficiently complete” to permit full review

- PMLiVE

ViiV and Janssen take long-acting HIV regimen into phase III

Cabotegravir and rilpivirine injectable-therapy tipped as future blockbuster

- PMLiVE

Dr Robert Califf confirmed as new head of the FDA

US Senate votes in favour of his appointment to lead the regulator

Novartis building

Novartis claims FDA breakthrough status for leukaemia treatment

Designation could speed up development and access for Novartis’ PKC412

- PMLiVE

Damian Eade rejoins Cello Health Insight

Takes up newly-created role as global head of digital

- PMLiVE

Ashfield Healthcare expands its board of directors

Seven new members join the board

Eli Lilly HQ

Lilly wins European approval for lung cancer drug Portrazza

First biologic licenced in EU as a first-line treatment for adults with NSCLC

- PMLiVE

Pharma forms Parkinson’s disease trials consortium

Hopes to make clinical trials “smarter” through sharing of past PD trial data

- PMLiVE

Breaking Down the Barriers to Behaviour Change by Patrick Ladbury

Patrick Ladbury, the Director at the NSMC delves further into the barriers to behaviour change, and offers us tricks of the trade in his second instalment.

Say Communications

Novo Nordisk adds to board of directors

Brian Daniels elected to join the board

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links